1 day 10 hours ago
Diabetic ketoacidosis (DKA) occurring after diabetes diagnosis is often associated with risk factors for other diabetes-related complications. We aimed to determine the prognostic implications of DKA on all-cause mortality and complications in type 1 diabetes (T1D).
Dalton R. Budhram, Priya Bapat, Abdulmohsen Bakhsh, Mohammad I. Abuabat, Natasha J. Verhoeff, Doug Mumford, Andrej Orszag, Akshay Jain, David Z.I. Cherney, Michael Fralick, Alanna Weisman, Leif Erik Lovblom, Bruce A. Perkins
1 week 1 day ago
Type 2 diabetes (T2D) management requires behavioural engagement to achieve optimal outcomes. Continuous glucose monitoring (CGM) facilitates self-management. This paper describes the development of the Impact of Glucose Monitoring on Self-Management Scale (IGMSS), assessing the impact of device use (CGM or SMBG) on capability, motivation, and opportunity for self-management.
Michael Vallis, Lori Berard, Emmanuel Cosson, Finn Boerlum Kristensen, Fleur Levrat-Guillen, Nicolas Naiditch, Remi Rabasa-Lhoret, William Polonsky
3 weeks 1 day ago
Evidence suggests that glucose levels in menstruating females with type 1 diabetes change throughout the menstrual cycle, reaching a peak during the luteal phase. The Type 1 Diabetes Exercise Initiative (T1DEXI) study provided the opportunity to assess glycemic metrics between early and late phases of the menstrual cycle, and whether differences could be explained by exercise, insulin, and carbohydrate intake.
Zoey Li, Jane E. Yardley, Dessi P. Zaharieva, Michael C. Riddell, Robin L. Gal, Peter Calhoun
3 weeks 3 days ago
To assess early adoption patterns of SGLT2 inhibitors (SGLT2i) in eligible patients with type 2 diabetes (T2DM) and heart failure with reduced ejection fracture (HFrEF) and identify gaps in practice.
Alaa Mohamed, Erin Keely, Kylie McNeill, Lisa M. Mielniczuk, Delvina Hasimja
3 weeks 4 days ago
Exercise is a recommended component of type 1 diabetes (T1D) treatment because high physical activity levels improve health outcomes. However, many people with T1D do not meet physical activity recommendations. Our aim in this study was to identify factors influencing physical activity levels in people with T1D.
Rakel Fuglsang Johansen, Sharon Caunt, Simon Heller, Sarah Elton Sander, Esben Søndergaard, Stig Molsted, Peter Lommer Kristensen
3 weeks 5 days ago
3 weeks 5 days ago
3 weeks 5 days ago
4 weeks 1 day ago
In this study we explore the impact of postprandial exercise timing (morning vs evening) on glycemia in individuals with type 1 diabetes (T1D) during short all-out sprints on a cycle ergometer.
Ilyess Aouin Chaieb, Faten Hadj Kacem, Mouna Mnif, Mouna Turki, Elsa Heyman, Omar Hammouda, Nadine Taleb, Mohamed Abid, Mariem Zouari, Rémi Rabasa-Lhoret, Mohamed Amine Bouzid, Sémah Tagougui
1 month 3 weeks ago
1 month 3 weeks ago
1 month 3 weeks ago
1 month 3 weeks ago
Current exercise recommendations for people with type 1 diabetes (PWT1D) are based on research involving primarily young, fit male participants. Recent studies have shown possible differences between male and female blood glucose response to exercise, but little is known about whether these differences are sex-related (due to physiological differences between male and female participants), or gender-related (behavioural differences between men and women).
Jessica E. Logan, Mason Prévost, Anne-Sophie Brazeau, Sarah Hart, Miranda Maldaner, Sarah Scrase, Jane E. Yardley
2 months ago
Our aim in this study was to develop and evaluate a tailored intervention for improving diabetes self-care among people with visual impairment (TID-VI) in South Korea.
Hee Jung Kim, Kyoung-eun Lee, Eunjin Yang, Sun Ju Chang
2 months 2 weeks ago
Expert guidelines recommend an aerobic cooldown to lower blood glucose for the management of post-exercise hyperglycemia. This strategy has never been empirically tested. Our aim in this study was to compare the glycemic effects of performing an aerobic cooldown vs not performing a cooldown after a fasted resistance exercise session. We hypothesized that the cooldown would lower blood glucose in the 30 minutes after exercise and would result in less time in hyperglycemia in the 6 hours after exercise.
Reid D. McClure, Alice L.J. Carr, Normand G. Boulé, Jane E. Yardley
2 months 4 weeks ago
Pharmacologic treatment of type 2 diabetes mellitus (T2DM) follows a stepwise approach. Typically, metformin monotherapy is first-line treatment, followed by other noninsulin antihyperglycemic agents (NIAHAs) or progression to insulin if glycated hemoglobin (A1C) targets are not achieved. We aimed to describe real-world patterns of basal insulin initiation in people with T2DM, and A1C not at target despite treatment with at least 2 NIAHAs.
Peter Senior, Jina Hahn, Godfrey Mau, Phongsack Manivong, Eileen Shaw
3 months ago
The Hypoglycemia During Hospitalization (HyDHo) score predicts hypoglycemia in a population of Canadian inpatients by assigning various weightings to 5 key clinical criteria known at the time of admission, in particular age, recent presentation to an emergency department, insulin use, use of oral hypoglycemic agents, and chronic kidney disease. Our aim in this study was to externally validate the HyDHo score by applying this risk calculator to an Australian population of inpatients with diabetes.
Lauren Di Salvo, Rahul D. Barmanray, Evelyn Andrews, Mervyn Kyi, Timothy N. Fazio, Julia Lowe, Spiros Fourlanos
3 months 1 week ago
The purpose of this qualitative study is to identify barriers minimizing the effectiveness of motivational interviewing during virtual clinic encounters for individuals with type 2 diabetes based on the capability, opportunity, motivation, and behaviour (COM-B) model.
Kimberley Lau, Carlos Escudero, Irene Lee, Catherine Yu
3 months 1 week ago
The objectives of this study were 1) to examine and compare changes in functional limitations during the COVID-19 pandemic among older adults with and without diabetes; and 2): to identify key risk factors associated with developing functional limitations among older adults with and without diabetes during the pandemic.
Andie MacNeil, Susanna Abraham Cottagiri, Paul J. Villeneuve, Ying Jiang, Margaret de Groh, Esme Fuller-Thomson
3 months 1 week ago
Our aim in this study was to systematically assess the association of sodium-glucose cotransporter-2 inhibitors (SGLT2i) vs dipeptidyl peptidase-4 inhibitors (DPP4i) with pneumonia, COVID-19, and adverse respiratory events in patients with type 2 diabetes mellitus (DM).
Mengna Wang, Ming Li, Libin Wang, Fang Wang, Xulin Cao, Shengyou Li, Zhichang Zheng
Checked
1 hour 8 minutes ago
Canadian Journal of Diabetes RSS feed.
Subscribe to Canadian Journal of Diabetes feed
